Effects of tachyplesin and n-sodium butyrate on proliferation and gene expression of human gastric a

来源 :世界胃肠病学杂志(英文版) | 被引量 : 0次 | 上传用户:huangxl2000
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: To investigate the effects of tachyplesin and n-sodium butyrate on proliferation and gene expression of human gastric adenocarcinoma cell line BGC-823.METHODS: Effects of tachyplesin and n-sodium butyrate on proliferation of BGC-823 cells were determined with trypan blue dye exclusion test and HE staining. Effects of tachyplesin and n-sodium butyrate on cell cycle were detected by flow cytometry. Protein levels of c-erbB-2, c-myc, p53 and p16 were examined by immunocytochemistry.RESULTS: The inhibiting effects were similar after 2.0 mg/L tachyplesin and 2.0 mmol/L n-sodium butyrate treatment, the inhibitory rate of cellular growth was 62.66% and 60.19% respectively, and the respective maximum mitotic index was decreased by 49.35% and 51.69% respectively. Tachyplesin and n-sodium butyrate treatment could markedly increase the proportion of cells at G0/G1 phase and decrease the proportion at S phase.The expression levels of oncogene c-erbB-2, c-myc, and mtp53 proteins were down-regulated while the expression level of tumor suppressor gene p16 protein was up-regulated after the treatment with tachyplesin or n-sodium butyrate. The effects of 1.0 mg/L tachyplesin in combination with 1.0 mmol/L n-sodium butyrate were obviously superior to their individual treatment in changing cell cycle distribution and expression of c-erbB-2,c-myc, mtp53 and p16 protein. The inhibitory rate of cellular growth of BGC-823 cells after combination treatment was 62.29% and the maximum mitotic index was decreased by 51.95%.CONCLUSION: Tachyplesin as a differentiation inducer of tumor cells has similar effects as n-sodium butyrate on proliferation of tumor cells, expression of correlative oncogene and tumor suppressor gene. It also has a synergistic effect on differentiation of tumor cells.
其他文献
目的:观察研究微创小切口手术治疗单纯性阑尾炎的临床疗效.方法:选取我院于2016年4月——2017年4月期间收治的120例单纯性阑尾炎患者,随机分成两组,对照组与观察组,对照组采
期刊
AIM: To study the main environmental and lifestyle factors that account for the regional differences in esophageal cancer (EC) risk in low- and high-risk areas
目的检测急性坏死性胰腺炎(ANP)大鼠胰腺组织高迁移率族蛋白B1(HMGB1)mRNA表达量,观察血清HMGB1水平的变化规律。方法采用腹腔注射20% L-精氨酸250 mg/100 g体重2次、间隔1 h的方法制备ANP大鼠模型,以腹腔注射等容积生理盐水作为对照组。注射后6、18、24、36、48、72、96 h分批处死大鼠,取血检测血清淀粉酶及HMGB1水平;取胰腺组织常规行病理学检查;采用实
目的:对肺结核X线诊断及临床表现、治疗进行探析.方法:回顾性研究2014年1月~2016年12月我院诊治的105例肺结核患者临床资料,均接受胸X线片检查,分析检查结果,并总结临床表现和
目的评价经腹膜后路径微创技术治疗重症急性胰腺炎(SAP)合并胰周坏死的疗效。方法回顾性分析南华大学附属第一医院肝胆胰外科2016年1月至2016年9月收治的10例在常规综合治疗的基础上采取B超引导下经腹膜后间隙穿刺置管引流术治疗的SAP合并胰周坏死患者的临床资料。结果10例患者均穿刺成功。7例患者穿刺置管后引流通畅,3~7 d淀粉酶恢复正常,2~4 d腹痛、腹胀症状明显好转;3例因坏死范围较大及置
目的探讨刺五加干预对大鼠的潜在保护/毒性作用。方法应用随机数字表法将20只雄性SD大鼠分为刺五加组和对照组,每组10只。刺五加组大鼠给予刺五加提取物31.6 mg/kg(相当于人类的生药量0.386 g/kg)灌胃,灌胃药物的容积为10 ml/kg,对照组给予等容积0.9%氯化钠溶液灌胃,均为1次/d,连续20 d。分别于灌胃1、5、10、15、20 d收集2组大鼠24 h尿液,应用超高效液相色谱
目的分析在新疆喀什地区应用羊膜治疗严重眼表病的临床效果。方法收集2017年1月至12月因常见致病微生物引起的角膜溃疡住院手术治疗的50例(50眼)为治疗组,2016年3月至9月因相同致病微生物引起的角膜溃疡住院药物治疗的50例(50眼)为对照组。对比两组患者并发症发生率、有效率、复发率、住院天数和住院费用。结果治疗组和对照组:并发症发生率分别是8.00%和36.00%,差异有统计学意义(P=0.0
目的探讨替比夫定(LdT)与阿德福韦酯(ADV)联用对慢性乙型肝炎(CHB)患者肾功能的影响。方法研究对象为就诊于浙江中医药大学附属第一医院、因LAM耐药联合应用ADV后出现肾功能损伤的CHB患者,研究设计为随机对照试验。用随机数字表法将患者分为继续应用原治疗方案组(LAM + ADV组)和以LdT替换LAM组(LdT+ADV组),比较2组患者入组时和治疗第24、48周HBV DNA、丙氨酸转氨酶